BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34434578)

  • 1. Proton beam therapy with concurrent chemotherapy is feasible in children with newly diagnosed rhabdomyosarcoma.
    Suzuki R; Fukushima H; Okuwaki H; Inaba M; Hosaka S; Yamaki Y; Fukushima T; Masumoto K; Mizumoto M; Sakurai H; Takada H
    Rep Pract Oncol Radiother; 2021; 26(4):616-625. PubMed ID: 34434578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 5. Tailor-made treatment combined with proton beam therapy for children with genitourinary/pelvic rhabdomyosarcoma.
    Fukushima H; Fukushima T; Sakai A; Suzuki R; Kobayashi C; Oshiro Y; Mizumoto M; Hoshino N; Gotoh C; Urita Y; Komuro H; Kaneko M; Sekido N; Masumoto K; Sakurai H; Sumazaki R
    Rep Pract Oncol Radiother; 2015; 20(3):217-22. PubMed ID: 25949226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors.
    Nakao T; Fukushima H; Fukushima T; Suzuki R; Hosaka S; Yamaki Y; Kobayashi C; Iwabuchi A; Imagawa K; Sakai A; Shinkai T; Masumoto K; Sakashita S; Masumoto T; Mizumoto M; Sumazaki R; Sakurai H
    Rep Pract Oncol Radiother; 2018; 23(5):442-450. PubMed ID: 30197580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis.
    Dong M; Wu J; Wu R; Wang D; Liu R; Luo H; Wang Y; Chen J; Ou Y; Zhang Q; Wang X
    Radiat Oncol; 2023 Feb; 18(1):31. PubMed ID: 36805784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary Experience of Treating Children and Young Adults With Image-Guided Proton Beam Therapy in India.
    Chilukuri S; Burela N; Uppuluri R; Indumathi D; Nangia S; Panda PK; Shamurailatpam DS; Raj R; Raja T; Jalali R
    JCO Glob Oncol; 2020 Nov; 6():1736-1745. PubMed ID: 33180633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma.
    Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Radiother Oncol; 2019 May; 134():143-150. PubMed ID: 31005208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
    Hwang E; Gaito S; France A; Crellin AM; Thwaites DI; Ahern V; Indelicato D; Timmermann B; Smith E
    Clin Oncol (R Coll Radiol); 2023 May; 35(5):292-300. PubMed ID: 36813694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma.
    Ladra MM; Szymonifka JD; Mahajan A; Friedmann AM; Yong Yeap B; Goebel CP; MacDonald SM; Grosshans DR; Rodriguez-Galindo C; Marcus KJ; Tarbell NJ; Yock TI
    J Clin Oncol; 2014 Nov; 32(33):3762-70. PubMed ID: 25332253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
    Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
    Jazmati D; Butzer S; Hero B; Ahmad Khalil D; Merta J; Bäumer C; Plum G; Fuchs J; Koerber F; Steinmeier T; Peters S; Doyen J; Thole T; Schmidt M; Blase C; Tippelt S; Eggert A; Schwarz R; Simon T; Timmermann B
    Front Oncol; 2020; 10():617506. PubMed ID: 33552991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategies and outcomes for spinal rhabdomyosarcoma: A series of 11 cases in a single center and review of the literature.
    Wang T; Gao X; Yang J; Guo W; Wu Z; Tang L; Cao S; Cai X; Liu T; Jia Q; Xiao J
    Clin Neurol Neurosurg; 2020 May; 192():105729. PubMed ID: 32058205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
    Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses.
    Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
    Front Oncol; 2020; 10():572493. PubMed ID: 33102230
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.
    Saeed AM; Khairnar R; Sharma AM; Larson GL; Tsai HK; Wang CJ; Halasz LM; Chinnaiyan P; Vargas CE; Mishra MV
    Adv Radiat Oncol; 2020; 5(5):978-983. PubMed ID: 33083661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.
    Indelicato DJ; Rotondo RL; Krasin MJ; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Morris CG; Bradley JA
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):968-976. PubMed ID: 31987977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.